VITT and Second Doses of Covid-19 Vaccine

N Engl J Med. 2022 Jan 6;386(1):95. doi: 10.1056/NEJMc2118507. Epub 2021 Dec 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antibodies, Viral
  • COVID-19 Vaccines* / adverse effects
  • ChAdOx1 nCoV-19 / adverse effects*
  • Female
  • Humans
  • Immunization, Secondary*
  • Male
  • Middle Aged
  • Platelet Factor 4 / immunology
  • Purpura, Thrombocytopenic, Idiopathic / etiology
  • Recurrence
  • SARS-CoV-2 / immunology
  • Spike Glycoprotein, Coronavirus / immunology
  • Thrombocytopenia / etiology*
  • Thrombosis / etiology*

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • Platelet Factor 4
  • ChAdOx1 nCoV-19